Skip to main content
Caplight Logo









Biofortuna

Biofortuna

Private
DeesideHealthcare & Life Scienceshttps://www.biofortuna.com/

Last Round

VC Round

Aug 15, 2017

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Biofortuna is a life sciences company that provides contract development, manufacturing, and laboratory services for diagnostic and biotechnology sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOmolecular diagnosticscontract manufacturinglyophilizationassay developmentin vitro diagnosticIVDfreeze-drying servicesISO 13485clinical trial supportdiagnostic kit manufacturingreagent stabilizationbiotech manufacturingwhite label diagnosticsCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biofortuna Comparables

Compare Biofortuna with similar companies based on industry and business-model similarity.

Biofortuna comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IVD Research, Inc.
79%
Avioq, Inc.
78%
Lyophilization Technology, Inc.
77%

Biofortuna Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 15, 2017
VC RoundJan 29, 2015
VC RoundAug 20, 2013
VC RoundApr 11, 2012
VC RoundMay 25, 2010

Key People

Founding team and executive leadership

Nick Ash

CEO

Executive Team

Nick Leaves

Chief Operating Officer

Executive Team

Biofortuna Investors

Notable investors and investment history

Biofortuna investors
InvestorRounds
Merseyside Special Investment FundVC Round
Foresight Group LLPVC Round
Mercia Asset ManagementVC Round
Catapult VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 124% MoM, reaching 2.5K.

  • Aug 15, 2017

    $2.1M round led by Foresight VCTs.

Biofortuna Filings

Explore SEC and related filing metadata, where available.

Biofortuna filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biofortuna's valuation, stock price, and market status.

Is Biofortuna a public or private company?

Biofortuna is a private company.

What is the current stock price of Biofortuna?

Biofortuna is a private company with no public stock price. No recent secondary market data is available.

How much is Biofortuna worth (valuation)?

Valuation information for Biofortuna is not publicly available.

Can I buy Biofortuna stock?

Biofortuna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biofortuna's last funding round?

Biofortuna's most recent funding round was VC Round on August 15, 2017.

Who are the main investors in Biofortuna?

Key investors in Biofortuna include Foresight Group LLP.

Will Biofortuna IPO soon?

No public IPO plans have been announced for Biofortuna.

How can I track Biofortuna secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biofortuna's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDeeside
Employee Range31
Year Founded2008
Last FundingAug 15, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?